UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001529 |
|---|---|
| Receipt number | R000001846 |
| Scientific Title | Phase II trial of irinotecan plus cisplatin for pretreated patients with Ewing sarcoma and PNET |
| Date of disclosure of the study information | 2008/12/01 |
| Last modified on | 2018/12/13 12:25:58 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/11/26 18:26:56 | ||
| 2 | Update | 2008/12/02 16:34:05 | Acronym Acronym |
|
| 3 | Update | 2008/12/03 19:53:37 | Acronym Acronym |
|
| 4 | Update | 2009/05/28 13:40:03 | Email1 |
|
| 5 | Update | 2018/12/13 12:21:37 | Recruitment status Other related information |
|
| 6 | Update | 2018/12/13 12:25:58 | Last name of lead principal investigator Last name of lead principal investigator TEL Last name of contact person Last name of contact person Address TEL Name of person sending information Organization Division name Address Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
